oxybutynin has been researched along with betadex in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sui, G; Sun, G; Tang, K; Yang, W; Zhang, P; Zhou, C | 1 |
| Gao, ZS; Wang, L; Zhang, M | 1 |
| Al-Shar'i, N; Athamneh, T; Obaidat, R; Tashtoush, B | 1 |
| Dahiya, L; Kumar, R; Sarwal, A; Sinha, VR | 1 |
4 other study(ies) available for oxybutynin and betadex
| Article | Year |
|---|---|
Enantiomeric separation of oxybutynin by recycling high-speed counter-current chromatography with hydroxypropyl-β-cyclodextrin as chiral selector.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Countercurrent Distribution; Mandelic Acids; Stereoisomerism | 2014 |
[Effects of penetration enhancers on curcumin transdermal drug delivery].
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Cutaneous; Animals; beta-Cyclodextrins; Camphanes; Chemistry, Pharmaceutical; Curcumin; Drug Carriers; Drug Delivery Systems; In Vitro Techniques; Mentha piperita; Mice; Mice, Inbred ICR; Permeability; Plant Oils; Skin; Skin Absorption; Transdermal Patch | 2012 |
Enhancement of levodopa stability when complexed with β-cyclodextrin in transdermal patches.
Topics: Acrylates; Administration, Cutaneous; Animals; Antiparkinson Agents; beta-Cyclodextrins; Crystallography, X-Ray; Drug Combinations; Drug Stability; Levodopa; Male; Polysaccharides, Bacterial; Rats; Rats, Sprague-Dawley; Sequestering Agents; Transdermal Patch; X-Ray Diffraction | 2018 |
Transdermal delivery of duloxetine-sulfobutylether-β-cyclodextrin complex for effective management of depression.
Topics: Administration, Cutaneous; Animals; beta-Cyclodextrins; Depression; Duloxetine Hydrochloride; Rats; Rats, Wistar; Skin; Skin Absorption; Transdermal Patch | 2021 |